First inhaled lentiviral gene therapy enters cystic fibrosis trial
News in Brief Published: 17 March 2025 Nature Biotechnology volume 43, page 288 (2025)Cite this article A potential first-in-class treatment using a lentivirus-based CFTR gene addition therapy for cystic fibrosis has begun